209 related articles for article (PubMed ID: 36356998)
41. SARS-CoV-2 tests, confirmed infections and COVID-19-related hospital admissions in children and young people: birth cohort study.
Hardelid P; Favarato G; Wijlaars L; Fenton L; McMenamin J; Clemens T; Dibben C; Milojevic A; Macfarlane A; Taylor J; Cunningham S; Wood R
BMJ Paediatr Open; 2022 Aug; 6(1):. PubMed ID: 36053647
[TBL] [Abstract][Full Text] [Related]
42. Shaping care home COVID-19 testing policy: a protocol for a pragmatic cluster randomised controlled trial of asymptomatic testing compared with standard care in care home staff (VIVALDI-CT).
Adams N; Stirrup O; Blackstone J; Krutikov M; Cassell JA; Cadar D; Henderson C; Knapp M; Goscé L; Leiser R; Regan M; Cullen-Stephenson I; Fenner R; Verma A; Gordon A; Hopkins S; Copas A; Freemantle N; Flowers P; Shallcross L
BMJ Open; 2023 Nov; 13(11):e076210. PubMed ID: 37963697
[TBL] [Abstract][Full Text] [Related]
43. Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.
Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Andreas Deckert AD; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
Scand J Work Environ Health; 2022 Sep; 48(7):588-590. PubMed ID: 36153787
[TBL] [Abstract][Full Text] [Related]
44. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
[TBL] [Abstract][Full Text] [Related]
45. Risk of COVID-19 hospital admission among children aged 5-17 years with asthma in Scotland: a national incident cohort study.
Shi T; Pan J; Katikireddi SV; McCowan C; Kerr S; Agrawal U; Shah SA; Simpson CR; Ritchie LD; Robertson C; Sheikh A;
Lancet Respir Med; 2022 Feb; 10(2):191-198. PubMed ID: 34861180
[TBL] [Abstract][Full Text] [Related]
46. SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.
Halford S; Wan S; Dragoni I; Silvester J; Nazarov B; Anthony D; Anthony S; Ladds E; Norrie J; Dhaliwal K;
Trials; 2021 Aug; 22(1):550. PubMed ID: 34412682
[TBL] [Abstract][Full Text] [Related]
47. Retrospective cohort study to evaluate medication use in patients hospitalised with COVID-19 in Scotland: protocol for a national observational study.
Mueller T; Kerr S; McTaggart S; Kurdi A; Vasileiou E; Docherty A; Fraser K; Shi T; Simpson CR; Bennie M; Sheikh A
BMJ Open; 2021 Nov; 11(11):e054861. PubMed ID: 34799365
[TBL] [Abstract][Full Text] [Related]
48. COVID-19 risk factors amongst 14,786 care home residents: an observational longitudinal analysis including daily community positive test rates of COVID-19, hospital stays and vaccination status in Wales (UK) between 1 September 2020 and 1 May 2021.
Hollinghurst J; Hollinghurst R; North L; Mizen A; Akbari A; Long S; Lyons RA; Fry R
Age Ageing; 2022 May; 51(5):. PubMed ID: 35511729
[TBL] [Abstract][Full Text] [Related]
49. Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis.
Harwood R; Yan H; Talawila Da Camara N; Smith C; Ward J; Tudur-Smith C; Linney M; Clark M; Whittaker E; Saatci D; Davis PJ; Luyt K; Draper ES; Kenny SE; Fraser LK; Viner RM
EClinicalMedicine; 2022 Feb; 44():101287. PubMed ID: 35169689
[TBL] [Abstract][Full Text] [Related]
50. Predictive model for long COVID in children 3 months after a SARS-CoV-2 PCR test.
Nugawela MD; Stephenson T; Shafran R; De Stavola BL; Ladhani SN; Simmons R; McOwat K; Rojas N; Dalrymple E; Cheung EY; Ford T; Heyman I; Crawley E; Pinto Pereira SM
BMC Med; 2022 Nov; 20(1):465. PubMed ID: 36447237
[TBL] [Abstract][Full Text] [Related]
51. Mental health in the COVID-19 pandemic: A longitudinal analysis of the CLoCk cohort study.
Panagi L; White SR; Pinto Pereira SM; Nugawela MD; Heyman I; Sharma K; Stephenson T; Chalder T; Rojas NK; Dalrymple E; McOwat K; Simmons R; Swann O; ; Ford T; Shafran R
PLoS Med; 2024 Jan; 21(1):e1004315. PubMed ID: 38266043
[TBL] [Abstract][Full Text] [Related]
52. Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study.
Shrotri M; Krutikov M; Nacer-Laidi H; Azmi B; Palmer T; Giddings R; Fuller C; Irwin-Singer A; Baynton V; Tut G; Moss P; Hayward A; Copas A; Shallcross L
Lancet Healthy Longev; 2022 Jul; 3(7):e470-e480. PubMed ID: 35813279
[TBL] [Abstract][Full Text] [Related]
53. Prospective cohort study of children with suspected SARS-CoV-2 infection presenting to paediatric emergency departments: a Paediatric Emergency Research Networks (PERN) Study Protocol.
Funk AL; Florin TA; Dalziel SR; Mintegi S; Salvadori MI; Tancredi DJ; Neuman MI; Payne DC; Plint AC; Klassen TP; Malley R; Ambroggio L; Kim K; Kuppermann N; Freedman SB
BMJ Open; 2021 Jan; 11(1):e042121. PubMed ID: 33452195
[TBL] [Abstract][Full Text] [Related]
54. Ethnic and social inequalities in COVID-19 outcomes in Scotland: protocol for early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II).
Henery P; Vasileiou E; Hainey KJ; Buchanan D; Harrison E; Leyland AH; Alexis T; Robertson C; Agrawal U; Ritchie L; Stock SJ; McCowan C; Docherty A; Kerr S; Marple J; Wood R; Moore E; Simpson CR; Sheikh A; Katikireddi SV
BMJ Open; 2021 Aug; 11(8):e048852. PubMed ID: 34376451
[TBL] [Abstract][Full Text] [Related]
55. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
56. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
[TBL] [Abstract][Full Text] [Related]
57. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
[TBL] [Abstract][Full Text] [Related]
58. Impact of first UK COVID-19 lockdown on hospital admissions: Interrupted time series study of 32 million people.
Shah SA; Brophy S; Kennedy J; Fisher L; Walker A; Mackenna B; Curtis H; Inglesby P; Davy S; Bacon S; Goldacre B; Agrawal U; Moore E; Simpson CR; Macleod J; Cooksey R; Sheikh A; Katikireddi SV
EClinicalMedicine; 2022 Jul; 49():101462. PubMed ID: 35611160
[TBL] [Abstract][Full Text] [Related]
59. COVID-19 symptom surveillance in immunocompromised children and young people in the UK: a prospective observational cohort study.
Shaunak M; Patel R; Driessens C; Mills L; Leahy A; Gbesemete D; Owens DR; Lucas JS; Faust SN; de Graaf H;
BMJ Open; 2021 Mar; 11(3):e044899. PubMed ID: 33737439
[TBL] [Abstract][Full Text] [Related]
60. Estimating the incidence, prevalence and true cost of asthma in the UK: secondary analysis of national stand-alone and linked databases in England, Northern Ireland, Scotland and Wales-a study protocol.
Mukherjee M; Gupta R; Farr A; Heaven M; Stoddart A; Nwaru BI; Fitzsimmons D; Chamberlain G; Bandyopadhyay A; Fischbacher C; Dibben C; Shields M; Phillips C; Strachan D; Davies G; McKinstry B; Sheikh A;
BMJ Open; 2014 Nov; 4(11):e006647. PubMed ID: 25371419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
